First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
Preprint in medRxiv (January 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Preprint in medRxiv (January 2024)
Article in Targeted Oncology (November 2023)
Article in Frontiers in Oncology (February 2022)